Skip to content
LexBuild

Importer of Controlled Substances; Notice of Application; Rhodes Technologies

---
identifier: "/us/fr/2012-10043"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Importer of Controlled Substances; Notice of Application; Rhodes Technologies"
title_number: 0
title_name: "Federal Register"
section_number: "2012-10043"
section_name: "Importer of Controlled Substances; Notice of Application; Rhodes Technologies"
positive_law: false
currency: "2012-04-26"
last_updated: "2012-04-26"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Justice Department"
document_number: "2012-10043"
document_type: "notice"
publication_date: "2012-04-26"
agencies:
  - "Justice Department"
  - "Drug Enforcement Administration"
fr_citation: "77 FR 24984"
fr_volume: 77
---

#  Importer of Controlled Substances; Notice of Application; Rhodes Technologies

This is notice that on February 24, 2011, Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the following basic classes of controlled substances in schedule II:

| Drug | Schedule |
| --- | --- |
| Opium, Raw (9600) | II |
| Poppy Straw Concentrate (9670) | II |

The company plans to import the listed controlled substances in order to bulk manufacture controlled substances in Active Pharmaceutical Ingredient (API) form. The company distributes the manufactured APIs in bulk form to its customers.

Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (2007).

As noted in a previous notice published in the *Federal Register* on September 23, 1975, 40 FR 43745, all applicants for registration to import a basic class of any controlled substance  in schedules I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.

Dated: April 17, 2012.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.